Osteoarthritis Market Size, Growth, Role of AI, Biomarkers and Digital Health
Based on market forecasts, the osteoarthritis sector will expand from USD 9.32 billion in 2024 to USD 20.88 billion by 2034, experiencing a CAGR of 8.4%. In 2023, knee osteoarthritis led the market with a 49% share due to its high prevalence. Imaging tests dominated diagnostics, while North America held a 38% market share. Key players include Zimmer Biomet, Pfizer, GSK, Bayer, Merck, Mylan, Anika Therapeutics, Huons, and Johnson & Johnson.
Last Updated : 21 April 2026
Category: Therapeutic Area
Insight Code: 5136
Format: PDF / PPT / Excel